Table of Contents
Table of Contents
Skeletal muscle stores energy as phosphocreatine for very short, highly intense efforts. During a sprint or a heavy set, phosphocreatine donates its phosphate group to regenerate ATP within seconds. This process is faster than both glycolysis and oxidative metabolism. Supplementing with creatine raises the total muscle creatine content by roughly 20-40% for individuals who start below saturation. After an initial saturation period, a daily dose of roughly 3-5 grams maintains these elevated muscle stores in most adults. However, muscle creatine uptake is saturable and transporter-dependent. Once muscle stores are completely full, additional creatine does not raise them further and is simply excreted as creatinine.
HMB (β-hydroxy-β-methylbutyrate) operates through a different mechanism and is a metabolite of the amino acid leucine. Approximately 5% of dietary leucine is converted to HMB. It acts primarily on the protein balance equation by attenuating proteolysis, which is muscle protein breakdown. HMB also has a smaller effect on muscle protein synthesis through mTOR signaling. The standard dose used in the majority of positive trials is 3 grams, typically divided across the day. Attempting to get this amount from dietary leucine alone is not practical, as hitting 3 grams of HMB would require eating roughly 600 grams of protein.
Put simply, creatine is about output, while HMB is about preservation. Creatine fuels your work, meaning the size of your phosphocreatine pool limits how much work you can do before you have to slow down.
Creatine does not build muscle directly; instead, it allows you to train harder, and doing more work per session over months is what drives adaptation and muscle growth. The evidence supporting creatine is established and robust, making it the most rigorously studied ergogenic supplement in existence. Meta-analyses consistently show that it improves strength when combined with resistance training, and it is highly effective for sprint and jump performance.
In contrast, HMB does not fuel work but preserves lean mass. The evidence for HMB is mixed, and its strongest, most consistent results are found in populations in a catabolic state. This includes older adults, individuals on bed rest, people in a caloric deficit, and untrained individuals starting a new program. In well-trained athletes, the results are much less consistent, with some trials showing favorable shifts in fat-free mass and others showing nothing. HMB is most useful when you are in a caloric deficit, recovering from injury, returning from a layoff, over 50, or training in a high-volume block. It is least likely to provide additional benefits to a well-fed, well-trained twenty-five-year-old who is in a caloric surplus and consuming adequate protein.
The rationale for combining them is that they operate on opposite sides of the same equation. One acts on energy availability during work; the other on protein balance afterward. That is mechanistically coherent, and it is the reason the combination has been studied at all.
Evidence for this combination is supported, with an important caveat about study size. The most cited work is a set of 2020 trials from Fernández-Landa and colleagues in elite male rowers. Over 10 weeks, participants received placebo, creatine alone, HMB alone, or both. The combination group showed greater improvements in aerobic power during an incremental test than either supplement alone, and in a companion paper, the combination raised testosterone and the testosterone-to-cortisol ratio more than an additive effect would predict, though it did not reduce exercise-induced muscle damage.
The caveat that should always be stated alongside those results: there were seven participants per arm. That is a very small trial, and small trials overestimate effect sizes as a rule. The finding is genuinely interesting; it is not definitive.
More recently, a 2025 randomized crossover trial in GeroScience tested creatine plus HMB in 30 physically active adults aged 60 and over and reported improved functional strength that was not fully explained by increases in muscle mass. This is a promising extension into an older population, where the case for HMB is strongest in the first place.
What we would not claim: that the combination is proven superior to creatine alone for hypertrophy in trained young lifters. That trial has not been done.
The case for combining creatine and HMB is strongest for:
The case is weakest for a well-fed, well-trained young lifter in a surplus who is already taking 5 g of creatine. For that person, the incremental value over creatine alone is unproven, and we would rather say so than pretend otherwise.
After a saturation period, roughly 3-5 g/day maintains elevated muscle stores in most adults. Larger people and those with more muscle mass sit at the upper end. Loading (20 g/day for 5-7 days) saturates faster but is not required, since 5 g/day gets you to the same place in about three to four weeks.
The ceiling. This is the important part. Muscle creatine uptake is transporter-dependent and saturable. Once your muscle stores are full, additional creatine does not raise them further; it is simply excreted as creatinine. This is why doubling your creatine dose does nothing for muscle, and it is the specific problem the next ingredient is meant to address.
You will have seen the claim that 10 g/day is the new standard because it "doubles brain creatine." It is worth tracing that claim to its source, because the source is more modest than the headline.
It comes from a single dose-ranging study in adolescent females with persistent low mood, randomized to placebo or creatine at 2, 4, or 10 g/day for eight weeks. Mean frontal lobe phosphocreatine rose by 4.6%, 4.1%, and 9.1% in the 2, 4, and 10 g groups, respectively, while placebo fell by 0.7%.
Three things get lost in the retelling:
What the wider brain literature actually shows. Creatine supplementation raises brain creatine by something in the range of 3-10%, with substantial variability between people and between studies. Among young healthy adults, some trials at around 20 g/day for a week found no measurable increase at all. The blood-brain barrier restricts creatine entry, and the brain synthesizes a meaningful share of its own supply, which is precisely why the brain is harder to move than muscle, and why higher oral doses do not scale the way people assume.
Where higher doses do have support: acute metabolic stress rather than everyday use. A single large dose (0.35 g/kg) improved cognitive performance and cerebral high-energy phosphates during sleep deprivation, and 20 g/day has shown effects under experimental hypoxia. These are rescue conditions, not a case for permanently doubling your daily intake.
And the honest counterweight in the other direction. A 2025 randomized trial put 63 adults through a 7-day non-exercise wash-in followed by 12 weeks of supervised resistance training, comparing 5 g/day creatine against no supplement. Both groups gained roughly 2 kg of lean body mass, with no significant difference between them; the creatine group's early gain appeared before training began and was interpreted as fluid rather than tissue. That trial has real limitations. The control group received nothing but a placebo, and it sits against pooled data from 61 trials showing a fat-free mass benefit of around 1.4 kg. But anyone telling you the creatine literature is uniformly glowing has not read all of it.
Practical position. 5 g/day is the right default, and scaling toward roughly 0.1 g/kg is more defensible than a flat dose. A 100 kg man at 5 g is relatively underdosed compared with a 60 kg woman at the same amount. Going to 10 g adds nothing to muscle once you are saturated. If your goal is specifically central rather than muscular, 10 g is a defensible bet, but it is a bet on thin evidence, and you should know that going in. It also doubles your cost and raises serum creatinine further, which can muddy a routine kidney panel if your physician does not know you supplement.
This is the dose used in the substantial majority of positive trials, typically divided across the day. There is no strong evidence that more helps.
Can you just eat more leucine instead? Not practically. Because only about 5% of leucine converts to HMB, hitting 3 g of HMB from dietary leucine alone would require an implausible protein intake, on the order of 60 g of leucine, or roughly 600 g of protein. This is the honest case for HMB as a supplement rather than a food strategy.
It is worth noting the nuances that gets lost in marketing:
No. 5 g/day saturates muscle in three to four weeks. Loading only compresses the timeline.
Creatine's main reported effects are mild GI discomfort at high doses and an early increase in body mass from intracellular water. HMB is well tolerated at 3 g/day. Note that creatine raises serum creatinine, a normal consequence of higher creatine turnover rather than evidence of kidney injury, and this can confuse a routine blood panel if your physician does not know you are supplementing. Tell them.
Yes. Both creatine and HMB depend on maintained tissue levels rather than acute dosing.
No. Creatine's early weight gain reflects water drawn into muscle cells alongside creatine. HMB has no comparable osmotic effect.
Yes, and there is no interaction to worry about. Neither creatine nor HMB replaces adequate protein intake, roughly 1.6 g/kg/day upward for people training seriously. Supplements sit on top of that foundation, not in place of it.
Reaching 3 g of HMB from food would require roughly 600 g of protein daily, because only about 5% of leucine converts to HMB.
This article is for education. It is not medical advice, and nothing here is intended to diagnose, treat, cure, or prevent any disease. Talk to your physician before starting any supplement, particularly if you take medication or have a kidney, cardiovascular, or metabolic condition.
References:
DISCLAIMER: These statements have not been approved by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent disease.
